USPTO 2015–2025 USPTO PatentsView US Corporation

Aptapharma Inc.

USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Aptapharma ranks #34,295 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.

#34,295
of 49,997 US assignees by volume
11th percentile
by Innovation Score (22.6/100)
15.6
avg claims per patent
-83%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34295 · US Corporation #34,295 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 7 grants
  • MID-PACK #34,295/49,997
  • PHOTO-FINISH APR
  • CPC-NARROW A61K · 3 areas
  • INNOV-THIN 22.6/100
  • CLAIMS-RICH 15.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -83% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: APR Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aptapharma’s 22.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Aptapharma

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Aptapharma's Innovation Score is 22.6/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Aptapharma?

Each dot is one of Aptapharma’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aptapharma’s own 15.6 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Aptapharma vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 6.97.07.077.07.07.1 01020304050 Granted patents (volume) Avg claims / patent APR Co., Ltd. - 7, 2.14APRApre Instruments, Inc. - 7, 15.57Apre InstrumentsApresia Systems, Ltd. - 7, 11.43Apresia SystemsAprofol AG - 7, 14.71AprofolAqdot Limited - 7, 16AqdotAquarius Spectrum Ltd. - 7, 26.29Aquarius SpectrumAquimo Inc. - 7, 38.43AquimoAquis Wasser-Luft-Systeme, GmbH, Lindau Zweigniederlassung Rebstein - 7, 22.14Aquis Wasser-luft…Aptapharma Inc. - 7, 15.57Aptapharma
Aptapharma vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aptapharma's grants concentrate

Aptapharma Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2015. By volume, Aptapharma sits between APR Co., Ltd. and Aquis Wasser-Luft-Systeme, GmbH, Lindau Zweigniederlassung Rebstein.

Who files at Aptapharma's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Aptapharma holds 7 patents at rank #34,175, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Aptapharma

By rank, the assignees closest to #34,175 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Aptapharma's primary technology class.

Aptapharma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 11th percentile higher than 11% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152016201820192021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Aptapharma Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 14.3%
2016 1 14.3%
2018 1 14.3%
2019 3 42.9%
2021 1 14.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Aptapharma Inc.'s patent record in context - here's where to go next.

  • Aptapharma Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #34,295 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Aptapharma Inc. against APR Co., Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 22.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.